Dual‐Targeted Nanovesicles Induced Cancer Stem‐Like Cell Differentiation to Sensitize Hepatocellular Carcinoma Radiotherapy
Advanced Science · 2025
DOI: 10.1002/advs.202502409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Hongmei Cao und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Key Labo…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Neoplastic Stem Cells, Cell Differentiation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Municipal Science and Technology Commission Grant, Natural Science Foundation of Tianjin, China.
Abstract (Originalsprache)
Highly plastic cancer stem‐like cells (CSCs) in hepatocellular carcinoma (HCC) drive tumor heterogeneity, contributing to radiotherapy failure. Although inducing CSC differentiation is proven effective in leukemia, this approach is shown limited success in solid tumors due to the complex signaling networks that sustain CSC stemness. In this study, the synergistic effect of Pin1 and Notch1 in HCC is identified, which plays a pivotal role in maintaining the aggressiveness of CSCs and promoting radioresistance. Building on this discovery, biomimetic nanovesicles (CALT‐GM‐NVs) are engineered by infusing tumor cell membranes into liposomes, which exhibit superior binding affinity to CSCs. RNA sequencing reveals that CALT‐GM‐NVs downregulate oncogenic signaling pathways while upregulating those linked to differentiation and apoptosis. In vivo, CALT‐GM‐NVs significantly reduced CSC‐driven radiotolerance and improved radiotherapy efficacy in both cell line‐derived and patient‐derived HCC xenograft models. These findings highlight the potential of simultaneously targeting Pin1 and Notch1 to induce CSC differentiation and provide a promising radiosensitizer for improving HCC radiotherapy outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Key Laboratory of Radiopharmacokinetics for Innovative Drugs, Tianjin Institut…
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P.…
ORCID-Profile: Jianfeng Liu
Förderung
- National Natural Science Foundation of China
- Tianjin Municipal Science and Technology Commission Grant
- Natural Science Foundation of Tianjin, China
- Postdoctoral Fellowship Program of CPSF
- China Postdoctoral Science Foundation
- Special Research Fund for Central Universities
- Peking Union Medical College
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Cao, H., Wang, Q., Niu, Y., Wang, S., Jia, H., Wang, D., Liu, J., Yuan, W., Yang, L., & Liu, J. (2025). Dual‐Targeted Nanovesicles Induced Cancer Stem‐Like Cell Differentiation to Sensitize Hepatocellular Carcinoma Radiotherapy. Advanced Science. https://doi.org/10.1002/advs.202502409
Vancouver
Cao H, Wang Q, Niu Y, Wang S, Jia H, Wang D, et al. Dual‐Targeted Nanovesicles Induced Cancer Stem‐Like Cell Differentiation to Sensitize Hepatocellular Carcinoma Radiotherapy. Advanced Science. 2025. doi:10.1002/advs.202502409
BibTeX
@article{Cao2025,
author = {Cao, Hongmei and Wang, Qian and Niu, Yanan and Wang, Shuxiang and Jia, Haixue and Wang, Dianyu and Liu, Jinjian and Yuan, Wei and Yang, Lijun and Liu, Jianfeng},
title = {Dual‐Targeted Nanovesicles Induced Cancer Stem‐Like Cell Differentiation to Sensitize Hepatocellular Carcinoma Radiotherapy},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202502409}
}
EUVIMED